Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

TriVascular raises $60 million: European launch of the firm's Ovation abdominal aortic aneurysm stent graft later this year will be aided by $60 million in new funding led by Pinnacle Ventures, including a "Series C" equity financing and growth capital venture debt, the firm announced July 12. The low-profile stent system is designed to expand the patient population suitable for endovascular aortic repair by addressing a wider range of diseased anatomy, the company explains. European study implants began last March to support a CE mark application, and the firm commenced its U.S. pivotal study in May. A 2008 spinout from Boston Scientific headquartered in Santa Rosa, Calif., TriVascular notes that it also is developing a version of Ovation for thoracic aortic aneurysms (1"The Gray Sheet" April 7, 2008)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT029137

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel